Article
Complement‐targeted therapeutics: An emerging field enabled by academic drug discovery
9 Feb 2023
Abstract excerpt
Within a short few years, the number of complement inhibitors that are either approved for therapeutic application or evaluated in late-stage clinical trials has expanded remarkably. The sudden emergence of this target area in the pipelines of many biotech start-ups and even large pharmaceutical companies appears even more surprising when considering that the involvement of the complement system in various...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
